Amol

Method of action: Analgesic, Antacid, Antipyretic, Pain Reliever

Treatment option: Backache, Pain, Sore Throat, Headache, Influenza, Toothache, Heartburn, Migraine, Muscular Aches And Pains, Neuralgia

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Amol

Property	Description
Active Ingredients	Acetaminophen (Paracetamol) and Caffeine
Form	Solid Oral Pharmaceutical (Tablet or Capsule)
Pharmacological Class	Analgesic Combination
Common Use	Relief of mild to moderate discomfort and fever
Origin	Primarily Synthetic

What is Amol: Definition and Pharmacological Classification

Amol is defined as a combination medicinal product containing two distinct active ingredients: Acetaminophen (Paracetamol) and Caffeine. This formulation is classified within the pharmacological class of Analgesic Combinations because its primary function is to alleviate pain and reduce fever. Acetaminophen itself is a non-opioid analgesic and antipyretic agent that is clinically recognized as a first-line treatment for pain and fever globally. The finished product utilizes this primarily synthetic compound alongside the augmenting effects of Caffeine, a methylxanthine derivative and mild Central Nervous System (CNS) stimulant. This specific two-drug formulation is widely marketed globally under various names, indicating its established role in self-medication for common ailments.

Composition and General Therapeutic Purpose

The general therapeutic purpose of the Amol combination is to provide effective relief from mild to moderate discomfort, such as tension headaches or general body aches, and to assist in the reduction of elevated body temperature. Acetaminophen acts as the main agent for pain relief and fever reduction by modulating chemical signals in the brain, while Caffeine serves as an analgesic adjuvant, a substance added to enhance the effect of the primary analgesic. The synergistic effect of these two components has been supported by multiple pharmacological studies, demonstrating an enhanced therapeutic outcome compared to Acetaminophen used alone. This means the combination is medically favored when a heightened level of effectiveness is sought for typical discomfort.

The Form of Amol: Oral Systemic Preparation

Amol is prepared as a solid oral pharmaceutical preparation, most commonly manufactured as a tablet or capsule. This dosage form is intended for systemic administration, which signifies that the active substances are ingested and absorbed into the bloodstream to produce their effects throughout the body. The choice of an oral, systemic route ensures that both the Acetaminophen and the Caffeine are efficiently delivered to act centrally on the systems responsible for mediating pain and temperature. This form is positioned for adult patients seeking convenient, non-prescription over-the-counter (OTC) relief for widespread body discomfort rather than localized topical issues.

What side effects are possible with Amol?

Possible Side Effects and Safety Information for Amol

Regulatory authorities mandate comprehensive monitoring of all drugs to ensure patient safety, focusing particularly on Serious Adverse Drug Reactions (ADRs). For products like Amol, the safety profile is structured around the official definitions and requirements for reporting these reactions.

Adverse Reaction Monitoring

A Serious Adverse Drug Reaction is officially defined as any event that results in death, is life-threatening, requires or prolongs hospitalization, causes a birth defect or congenital anomaly, or results in disability or permanent damage. These are the highest-priority events for continuous surveillance.

Mandatory Reporting: Healthcare institutions and manufacturers are required to report all suspected serious adverse drug reactions, as well as those that are unexpected (not consistent with the product’s labeling), to the relevant governmental authorities.
Frequency and Classification: Specific classifications of adverse reactions by frequency (e.g., very common, common, rare) or by affected System-Organ Class are typically detailed in the full product monograph; however, general regulatory oversight focuses on the reporting criteria for seriousness rather than a high-level published frequency table.

Safety Status and Limitations

Safety oversight ensures continuous reassessment of a drug's risk profile throughout its lifecycle. Available high-level regulatory records from authorities like Health Canada indicate that the product status for Amol was noted as Cancelled Post Market as of a specific historical date (March 9, 2010), reflecting a formal change in its regulatory standing or availability in that jurisdiction.

This information reflects the formal, mandated safety and reporting requirements for the drug, structuring the official understanding of potential risks based on criteria established by government regulatory bodies.

Overdose and Emergency Response

Amol overdose presents a dual-toxicity risk documented by regulatory bodies, involving severe Hepatotoxicity from Acetaminophen and Central Nervous System/Cardiovascular effects from Caffeine. Initial manifestations commonly include Nausea, Vomiting, Anorexia, Pallor, and Diaphoresis. Critically, overt signs of severe toxicity, such as Upper Abdominal Pain and Jaundice, may be delayed for 24 to 48 hours. Severe documented outcomes include Fulminant Hepatic Failure, Renal Failure, and life-threatening events such as Seizures, Coma, and Cardiac Arrhythmias.

Immediate action is mandatory for any suspected overdose. Regulatory labeling dictates that users seek immediate medical attention and contact a Poison Control Center without waiting for symptoms to appear. The official management protocol involves the prompt administration of N-acetylcysteine (NAC), the specific antidote for Acetaminophen toxicity, complemented by required symptomatic and supportive treatment. Individuals with chronic alcohol misuse or pre-existing hepatic impairment are officially designated as being at an increased risk for severe hepatotoxicity. Treatment requires serial monitoring of Acetaminophen plasma concentrations and liver function tests to assess toxicity progression.

Therapeutic Uses of Amol

What Amol treats: main uses and benefits

Amol is indicated for the temporary management of mild to moderate physical discomfort across several common conditions. It is used to help address symptoms such as minor muscle aches, joint stiffness, and back discomfort. The medication is also utilized in a supportive role for the symptomatic relief of common tension-type headaches and to help reduce the feeling of minor nasal congestion associated with the common cold or flu. Amol works to contribute to patient comfort during these self-limiting episodes, allowing for better daily function. The therapeutic scope and usage parameters for Amol are established for these applications.

Quick Fact: Relief for temporary muscle and joint discomfort.

Amol is intended as a short-term intervention to assist individuals in managing acute, everyday discomfort.

Eligibility and Restrictions for Use

Who can and cannot use Amol?

This section describes the officially documented population eligibility and restrictions for using Amol (Acetaminophen and Caffeine combination) as defined in government regulatory labeling.

Contraindicated Populations (Must Not Use)

Amol is contraindicated and must not be used by individuals with a known Hypersensitivity (allergy) to Acetaminophen, Caffeine, or any other component. It is also contraindicated for patients with Severe Hepatic Impairment or Active Liver Disease and in those consuming three or more alcoholic drinks per day, due to the risk of acetaminophen-related hepatotoxicity.

Restricted Eligibility and Age Limitations

Amol is not recommended for Children under 12 years of age. Use is also not recommended during pregnancy or lactation due to the caffeine content, which may impact the fetus or infant.

Use requires special caution (restricted eligibility) in adult populations with Mild or Moderate Hepatic Impairment, Renal Impairment, or Glutathione-Depleted States (e.g., severe malnutrition or chronic alcoholism). Caution is also required for patients with pre-existing conditions like Arrhythmia or Hyperthyroidism due to the caffeine component. Adults and adolescents aged 12 and older are generally considered eligible for labeled use.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Amol is a combination medicinal product whose official interaction profile is defined by government regulatory documentation concerning its active ingredients, Acetaminophen and Caffeine.

Prohibited and Restricted Combinations

The most critical regulatory restriction is the formal contraindication against combining Amol with any other medicinal product containing acetaminophen. This is mandated to prevent the risk of acute hepatic failure due to exceeding the maximum safe dose. Furthermore, chronic heavy consumption of alcohol (ethanol) is severely restricted in official documents due to its documented effect of potentiating the hepatotoxic risk associated with the acetaminophen component.

Pharmacokinetic and Pharmacodynamic Interactions

Official labeling identifies several pharmacokinetic interactions related to the caffeine component's metabolism. Co-administration with CYP1A2 inhibitors, such as ciprofloxacin or fluvoxamine, is documented to reduce caffeine clearance, resulting in its increased systemic exposure and higher plasma concentration. The simultaneous intake of other caffeine sources (foods, beverages) is also restricted, as it causes a pharmacodynamic reinforcement, increasing the likelihood of additive central nervous system (CNS) stimulant effects.

Population-Specific Notes

Regulatory labeling includes a specific caution that the risk and severity of acetaminophen-related interactions are heightened in individuals with pre-existing hepatic impairment or liver disease, as their ability to clear both active components may be compromised.

Mechanism of Action

How Amol Works

Amol exerts its effects through multiple, distinct biological mechanisms to modulate systemic physiological processes. The primary action occurs within enzymatic domains by inhibiting the formation of prostaglandins in the central nervous system. This molecular interaction modifies early steps in the arachidonic acid cascade related to nociception and thermoregulation. The resulting physiological consequence is a dampening of central nociceptive signal propagation and the modulation of the hypothalamic set-point for thermoregulation.

Beyond this, the agent engages secondary, centralized mechanisms that influence the endocannabinoid and serotonergic pathways. This cascade modulates the central processing of afferent sensory inputs, supporting a regulated state within pathways associated with altered nociceptive thresholds. Additionally, Amol interacts with specific Transient Receptor Potential (TRP) channels. By influencing these channels, which are involved in sensory signaling, Amol contributes to a more regulated state within targeted neural pathways, resulting in downstream physiological adjustments that characterize the agent's pharmacological effect.

Dosage and Administration Information

How to Use Amol: Administration Guidelines

The usage of Amol, a combination analgesic, follows defined parameters focusing on the method, frequency, and maximum limits of the oral formulation.

Dosing and Administration Parameters

Parameter	Instruction
Route of Administration	The medication is taken orally (by mouth) as a solid tablet or capsule.
Standard Dosing	One to two units (tablets/capsules) per dose for adults 12 years and older.
Dosing Frequency	Administered as needed (PRN) with a minimum interval of four hours between individual doses.
Maximum Daily Limit	The total intake of Acetaminophen from all sources must not exceed 4,000 mg (4 g) in a 24-hour period.
Course Duration	Use is intended for short-term symptomatic management only.

Procedural Constraints and Special Populations

Certain procedural constraints apply to the use of this medication. A key restriction is that the total unit intake must not exceed six tablets or capsules in 24 hours. Furthermore, the medicine may be taken with or without food.

For specific patient groups, dose selection requires caution in older adults (geriatric patients) and those with severe hepatic or renal impairment. For these individuals, it is suggested to start at the lower end of the dosing range. This structured approach defines the protocol for administering Amol.

Recent Clinical Evidence

Research evidence / Overview of studies for Amol

Evidence for Use in Acute Mild to Moderate General Pain

Research examining Amol was studied for acute, mild to moderate general pain, which includes physical discomfort like minor body aches or joint stiffness. The primary body of evidence consists of short-term Randomized Controlled Trials (RCTs) and comprehensive meta-analyses that consolidate findings across multiple studies. These trials examined adult participants experiencing pain that was acute and non-malignant. Researchers monitored outcomes related to physical discomfort by measuring the overall change in pain intensity and the proportion of participants who experienced a defined level of relief within a specific timeframe after taking a single dose.

Studies report measurements of outcomes related to physical discomfort over intervals of typically four to six hours. Findings data show patterns related to the intensity of pain measured during these brief intervals when compared to control groups. This research provides insight into short-term changes in acute discomfort.

Evidence for Use in Episodic Tension-Type Headache

The combination product was evaluated in research exploring its effect on conditions associated with acute or disruptive episodes such as tension-type headaches. This evidence comes from short-term RCTs and aggregated meta-analyses that research examined adult patients with acute episodic headaches. The studies explored specific outcomes related to headache severity, such as the time required to achieve a pain-free status and the overall reduction in headache intensity. Findings describe patterns observed in the studies where participants was associated with changes in headache severity at specified time points (often 2 hours) post-administration. This evidence contributes to the broader evidence landscape for conditions associated with acute or disruptive episodes like TTH.

What Is Still Uncertain About Amol Research

A major gap remains in the area of long-term outcomes, as the core evidence base prioritizes trials assessing short-term or episodic symptom patterns. Data for certain groups remain insufficient, as the majority of studies included a generalized adult population. Evidence quality varies across studies when analyzing heterogeneous pain models, and specific findings may be subject to the conditions under which they were originally conducted.

Key Studies & References

Randomized Controlled Trials of Paracetamol-Caffeine Combinations for Acute Musculoskeletal Pain

Frequently Asked Questions (FAQ)

Common questions about Amol (FAQ)

Q: How quickly should I expect Amol to start working?

Studies examining the active component, Acetaminophen, suggest that systemic levels often peak within 30 minutes to two hours following oral administration. This window generally aligns with the expected onset of the medicine’s effects on discomfort and fever. Individual responses to medications may vary.

Q: Are there any common side effects of Amol that are not serious?

Regulatory documents describe certain reactions related to the Caffeine component. These commonly include temporary feelings of nervousness, restlessness, or jitteriness, as well as minor gastrointestinal discomfort or trouble sleeping. Official reporting focuses on serious adverse reactions.

Q: Does Amol cause drowsiness or make you tired?

The product contains Caffeine, which is classified as a central nervous system stimulant. Because of this component, Amol is generally not associated with causing drowsiness or fatigue. However, some regulatory documents mention that specific individuals may experience lightheadedness, and temporary sleep disturbances are noted as a potential side effect.

Q: Does Amol interact with caffeine?

Official product information advises against the co-administration of Amol with other sources of caffeine, including certain foods and beverages. This restriction is due to the potential for additive effects, which can increase the likelihood of nervousness, jitters, or heart rate changes.

Q: What is the maximum amount of time someone can safely use Amol?

Regulatory documents state that the use of Amol is intended for short-term management of symptoms, not for chronic use. Over-the-counter guidelines for this combination product generally advise use for no more than 10 days for pain or 3 days for fever. The stated time limits reflect the drug's approved scope for short-term use.

Q: Does Amol have a risk of withdrawal symptoms?

The Acetaminophen component is not generally considered habit-forming. However, chronic, prolonged, and high-dose exposure to the Caffeine component can be associated with physical dependence. The potential for withdrawal symptoms upon abrupt discontinuation is noted in official documents for the Caffeine component following such use.

Q: Can Amol affect blood pressure?

Due to the Caffeine component, a stimulant, official warnings advise caution for patients with pre-existing heart conditions, such as arrhythmia. Excessive caffeine intake from Amol and other sources is a consideration that may influence heart rate or blood pressure.

Q: Are there any dietary restrictions while taking Amol?

Official documentation contains a documented restriction regarding chronic heavy consumption of alcohol due to the potential for increased risk of liver toxicity related to the Acetaminophen component. Additionally, it is advised to avoid consuming large amounts of other caffeine-containing foods or drinks to minimize potential side effects.

Q: What are the main research findings about how effective Amol is?

Research evidence, primarily from short-term randomized controlled trials, has examined the combination product's effect on acute discomfort, such as mild to moderate pain and episodic tension-type headaches. Findings documented in these studies indicate patterns of pain intensity reduction when the product is compared to inactive controls, supporting its use for its labeled indications.

Q: Is Amol used for any purpose other than what is listed in the official documents?

Regulatory documentation for Amol is limited solely to the specific conditions detailed in the labeling, which includes the relief of mild to moderate discomfort and fever. The regulatory scope focuses solely on use for the officially stated indications.

Q: Why does Amol need to be taken a certain number of times a day?

The official product instructions establish a minimum time interval, typically four hours, between individual doses. This interval is necessary and based on the pharmacological properties of the active ingredients. The time frame is intended to support appropriate levels of the medicine while preventing the total safe daily limit from being exceeded.

Q: What is the purpose of the 'inactive ingredients' in Amol?

Inactive ingredients are defined in official documents as substances without a therapeutic effect on the body. They are necessary for the drug product's formulation, helping with its manufacture, ensuring stability, providing its physical form, and contributing to the delivery of the active ingredients.

Q: Are there any long-term side effects associated with Amol use?

Regulatory documents state that Amol is intended for short-term use. Official warnings highlight that chronic, prolonged use of analgesic products, particularly at high doses, is associated with a greater potential for long-term health concerns, primarily related to the liver and kidneys.

Q: Can Amol interfere with birth control pills?

Some authoritative sources suggest that certain combination products containing Acetaminophen and Caffeine may have a potential for interaction with hormonal contraceptives. This possibility is often linked to the shared metabolic pathways that process the components of both types of medicine.

Q: Can Amol affect my mood?

Due to the Caffeine component, a central nervous system agent, some individuals may experience effects on their mental state or mood. Potential side effects noted in official sources include temporary feelings of nervousness, restlessness, or irritability.

Q: Can I use Amol if I have a history of stomach problems?

Official warnings for combination products containing Acetaminophen and Caffeine include cautions for individuals with certain pre-existing gastrointestinal issues. This precaution is often noted due to the potential for mild irritation or complications in individuals with a history of conditions like a stomach ulcer.

Q: What should I do if I forget to take my usual amount of Amol?

Official instructions for medicines taken as needed typically state that if a dose is forgotten, it should be taken as soon as the patient remembers. The protocol requires adherence to the minimum time interval between doses. Regulatory warnings indicate that a double dose should not be taken to make up for a missed amount.

Q: Can Amol be used by people with asthma?

While asthma is not always listed as a direct contraindication for this specific combination, regulatory warnings for certain analgesic products include cautions for patients with pre-existing respiratory issues. This precaution reflects warnings sometimes noted in the analgesic class, depending on the full product formulation.

How should Amol be stored and disposed of?

Storage and Disposal Requirements for Amol

Amol (Acetaminophen and Caffeine) must be stored according to official regulatory conditions to ensure stability and safety.

Storage Conditions

Requirement	Official Labeled Instruction
Temperature	Store at controlled room temperature (e.g., below 25 C).
Protection	Protect from moisture and excessive heat; do not refrigerate or freeze.
Packaging	Keep the medicine in its original container and ensure the container is tightly closed.